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Abstract SNURF/RNF4 has been implicated in transcriptional
regulation and growth inhibition in a RING ¢nger-dependent
fashion. In this work, we show that SNURF mediates its own
ubiquitination in vitro in a ubiquitin-conjugating enzyme (E2)-
selective manner: SNURF acts as an E3 ligase with UbcH5A
and B, HHR6B (RAD6B), E2-25K, MmUbc7 and UbcH13, but
not with UbcH3, UbcM4, MmUbc6 or E2-20K. In contrast, the
well-characterized RING E3, AO7, functions only with mem-
bers of the UbcH5 family. Furthermore, depending on the E2
used, the ubiquitin modi¢cation manifests as mono- or multi-
ubiquitination. Mutation of conserved cysteine residues within
the RING ¢nger motif of SNURF abolishes the ubiquitination
in vitro and in intact cells. Size fractionation of murine embry-
onal carcinoma F9 cell proteins shows that the majority of
endogenous SNURF resides in salt-resistant v500-kDa com-
plexes, suggesting that SNURF functions as a RING compo-
nent in a multiprotein complex. Taken together, SNURF/RNF4
functions as an E3 ligase and this activity is closely linked to its
transcription regulatory functions.
< 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
SNURF (RNF4) is a small nuclear protein that encom-
passes a C3HC4 (RING-HC)-type RING motif at its C-ter-
minal domain [1]. RING ¢ngers are conserved, cysteine-rich
motifs which coordinate two zinc atoms in a ‘cross-brace’
fashion and have been shown to mediate protein^protein in-
teractions and multi-protein complex formation [2,3]. SNURF
was initially identi¢ed as a co-activator protein of steroid
receptors [1]. In addition to steroid receptors, SNURF enhan-
ces the activity of promoter speci¢city protein 1 (Sp1)-regu-
lated transcription [1,4,5]. SNURF can also act as a transcrip-
tional co-repressor when associated with a novel POZ-AT
hook-zinc ¢nger protein (PATZ) [6,7]. The RING ¢nger do-
main is mandatory for the ability of SNURF to coregulate
Sp1, PATZ, and activator protein of stromelysin gene (SPBP)
in transcription assays [4,7,8]. SNURF also interacts with
goosecoid-like (Gsc1) homeodomain transcription factor and
TRPS1 transcription factor (a repressor of GATA-mediated
transcription), but as in the case of steroid receptors, regions
N-terminal to the RING ¢nger appear be important for the
interactions [1,5,6,10]. Besides associating with transcription
factors, SNURF can bind DNA and mononucleosomes in a
RING domain-independent fashion. SNURF may, therefore,
play a role in the assembly of nucleoprotein structures [11].
Recently, many RING ¢nger proteins have been shown to
mediate ubiquitin-conjugating enzyme (E2)-dependent attach-
ment of ubiquitin (ubiquitination) to target proteins [12,13].
In particular, AO7 was used to show the necessity of the
RING ¢nger and its zinc-coordinating residues for interaction
with E2s and subsequent ability to form ubiquitin chains [12].
Modi¢cation by ubiquitin is essential for the degradation of a
large number of proteins, and it plays a central role in a
variety of cellular processes, including cell cycle regulation,
DNA repair, signal transduction, and transcriptional regula-
tion [14,15]. The 76-amino acid ubiquitin polypeptide contains
seven lysine residues where additional ubiquitins may be
added to form multi-ubiquitin chains. The physiological con-
sequence of ubiquitin modi¢cation depends on the nature of
the ubiquitin chain being formed. Degradation is generally
signaled by chain formation via lysine 48, while signal trans-
duction and histone modi¢cation require mono-ubiquitina-
tion, and lysine 63 linkages are important for DNA repair
and kinase activation [16]. Other ubiquitin chains (Lys6,
Lys11, Lys29) have been described in vitro [17] and in vivo
[18], but they are less well characterized. Ubiquitination of
proteins is achieved in three enzymatic steps. The ¢rst step
involves ATP-dependent activation of ubiquitin by a ubiqui-
tin-activating enzyme (E1), resulting in formation of a thio-
ester linkage between ubiquitin and E1. Activated ubiquitin is
then transferred to a ubiquitin-conjugating enzyme (E2) and
subsequently to a lysine residue of a substrate with the assis-
tance of an E3 ubiquitin protein ligase. E3s bind substrates
and thereby govern speci¢city of ubiquitination [19]. Two dis-
tinct classes of ubiquitin ligases have been established: HECT
(homologous to E6-AP carboxy-terminus) domain E3s and
RING ¢nger E3s [19,20]. The HECT domain E3s form thio-
ester intermediates with ubiquitin as a part of the process,
whereas the RING ¢nger E3s are thought to facilitate direct
transfer of ubiquitin from E2 to substrate, probably without
formation of covalent intermediates [12,19].
In this work, we show that SNURF possesses ubiquitin-
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conjugating enzyme (E2)-selective E3 ligase activity that is
dependent on its RING ¢nger domain in vitro and in vivo.
Furthermore, we show that this selectivity is not a general
feature of RING proteins and results in di¡ering patterns of
ubiquitin modi¢cation that may explain the varied e¡ects of
SNURF on regulatory proteins. Size fractionation of protein
complexes from F9 cells demonstrates that endogenous
SNURF resides in macromolecular protein complexes, sug-
gesting that SNURF functions as a RING component of a
multi-subunit regulatory complex.
2. Materials and methods
2.1. Materials
The protease inhibitors phenylmethylsulfonyl £uoride (PMSF), leu-
peptin, pepstatin A, aprotinin and iodoacetamide, and ubiquitin were
obtained from Sigma-Aldrich. MG-132 was purchased from Calbio-
chem. Glutathione-Sepharose 4B, pGEX-6P-1, Superose 6 HR 10/30
column, HMW gel ¢ltration calibration kit, PreScission1 Protease,
Hybond enhanced chemiluminescence (ECL) nitrocellulose membrane
and ECL detection reagents were from Amersham Biosciences. Horse-
radish peroxidase-conjugated anti-mouse IgG was from Zymed. RNA
polymerase II antibody (N-20) was from Santa Cruz Biotechnology.
HA.11 a⁄nity matrix was obtained from Nordic BioSite AB, and
GammaBind1 G-Sepharose was from Amersham Biosciences. Hem-
agglutinin (HA)-tagged ubiquitin expression vector (pMT123) was a
gift from Drs. Dirk Bohmann and Mathias Treier. pcDNA-FLAG-
SNURF, pcDNA-FLAG-SNURF mutants, and bacterial pGEX-5X-
1-SNURF expression constructs have been described [5,11]. Mouse E1
enzyme was puri¢ed from baculovirus-infected insect cells, E2 conju-
gases (E2-25K, HHR6B, UbcH3, UbcM4, UbcH5B, MmUbc6,
MmUbc7, E2-20K, UbcH13), and E3 ligase, glutathione S-transferase
(GST)-AO7, were expressed in Escherichia coli as described [12,21^
24]. E2-25K was the gift of Dr. Cecile Pickart [25], HHR6B was the
gift of Dr. Art Haas [17], UbcH3, UbcM4, E2-20K and mouse E1
constructs were the gift of Dr. Kazuhiro Iwai [26,27], UbcH13 was the
gift of Dr. Brian Druker [28]. GST-UbcH5A and rabbit E1 were
purchased from A⁄niti Research Products. [32P]Ubiquitin was syn-
thesized as described [29].
2.2. Cell culture and transfections
Murine embryonal carcinoma F9 and COS-1 cells were obtained
from American Type Culture Collection, and maintained in Dulbec-
co’s modi¢ed Eagle’s medium containing 10% fetal bovine serum, 25
U/ml of streptomycin and penicillin. F9 cells were cultured on 0.1%
gelatin-coated cell culture dishes. For transfections, 3.5U105 COS-1
cells were seeded on 6-cm dishes 24 h before transfection. Four hours
before the addition of plasmid DNA (2.5 Wg/dish) and FuGene 6
transfection reagent (Roche Molecular Biochemicals), the cells re-
ceived fresh medium. After 18 h of transfection, the medium was
changed, and after 36 h of transfection 1.5 WM MG-132 was added.
Cells were washed with phosphate-bu¡ered saline (PBS) and harvested
in PBS containing 10 mM iodoacetamide 48 h after transfection.
2.3. Immunoprecipitation
COS-1 cells transfected with HA-ubiquitin and FLAG-SNURF ex-
pression plasmids and treated with or without 1.5 WM MG-132 were
lysed in a bu¡er containing 50 mM Tris^HCl (pH 7.5), 150 mM
NaCl, 1% (v/v) Nonidet P-40, 15 mM MgCl2, 50 WM ZnCl2, 5 mM
EDTA, 1 mM dithiothreitol (DTT), 10 mM iodoacetamide and 1:200-
diluted protease inhibitor cocktail (Sigma). Cell lysates were clari¢ed
by centrifugation and pre-incubated with normalized mouse serum
(Calbiochem) and GammaBind G-resin. After centrifugation and
transfer of supernatants to new tubes, anti-HA a⁄nity matrix was
added and incubated at 4‡C overnight. Resins were washed four times
with lysis bu¡er and bound proteins were eluted with sodium dodecyl
sulfate (SDS) sample bu¡er lacking L-mercaptoethanol at 65‡C. Sam-
ples were centrifuged and L-mercaptoethanol was added to resin-free
supernatants that were subsequently heated at 95‡C for 5 min. Pro-
teins were fractionated by 15% SDS^polyacrylamide gel electrophore-
sis (PAGE), electroblotted onto a Hybond ECL membrane, and
SNURF was detected with anti-SNURF antibody and ECL detection
system.
2.4. Gel ¢ltration
SNURF coding sequence (BamHI-blunt/SalI) was cleaved from
pGEX-5X-1-SNURF plasmid and cloned into pGEX-6P-1 vector.
GST-SNURF was expressed in E. coli (BL21 CodonPlus DE3-RIL,
Stratagene) and puri¢ed on glutathione 4B Sepharose as described
[11]. The GST moiety was removed by using PreScission1 protease
in a bu¡er containing 50 mM Tris^HCl (pH 7.5), 350 mM NaCl, 0.8%
(v/v) Triton X-100, 0.1% (v/v) Nonidet P-40, 2 mM EDTA, 1 mM
DTT, 50 WM PMSF, and 10 WM ZnCl2, and the cleaved SNURF was
dialyzed against GF bu¡er (50 mM Tris^HCl (pH 7.8), 1 mM EDTA,
450 mM NaCl, 0.1% (v/v) Triton X-100, 0.5 mM PMSF, and 10%
(v/v) glycerol). F9 cells were lysed in the GF bu¡er by rotation for 30
min at 4‡C and the cell lysates were centrifuged at 14 000Ug for 20
min. Supernatants were ¢ltered through Spin-X (0.22 Wm, Costar)
columns. The cell lysate (V5 mg protein) or puri¢ed recombinant
SNURF (100 Wg) was size-fractionated on a Superose 6 HR 10/30
column in GF bu¡er at 0.3 ml/min, and 1-min fractions were col-
lected. In some experiments, the NaCl concentration of the F9 cell
lysates was increased to 650 mM and GF bu¡er containing 650 mM
NaCl was used as running bu¡er. Blue dextran 2000 (2000 kDa),
thyroglobulin (669 kDa), ferritin (440 kDa), catalase (232 kDa), and
aldolase (158 kDa) were used as molecular size markers. SNURF was
detected from the eluate fractions by immunoblotting with a rabbit
anti-SNURF antiserum raised against full-length SNURF produced
in bacteria.
2.5. In vitro ubiquitination
Bacterially expressed GST-SNURF or its mutants were bound on
glutathione 4B Sepharose and washed with 50 mM Tris^HCl (pH
7.4). GST-AO7 or GST-SNURFs (20 pmol) were incubated in a 30
Wl reaction mixture containing the E2 enzyme (100 ng), the E1 enzyme
(100 ng), 32P-labeled ubiquitin (40 000 dpm), and 2 Wl bacterial lysate
from BL21 E. coli transformed with pET15b [12]. Reaction bu¡er
consisted of 50 mM Tris^HCl (pH 7.4), 200 WM ATP, 0.5 mM
MgCl2, 0.1 mM DTT, 1 mM creatine phosphate, and 15 U of phos-
phocreatine kinase. Reactions were incubated at 30‡C for 2 h and
stopped by adding concentrated SDS^PAGE sample bu¡er. The pro-
teins were separated on 15% SDS^PAGE gels and detected by auto-
radiography. GST-cleaved SNURF protein (600 nM) was incubated
with GST-UbcH5A (200 nM) and E1 (30 nM), ubiquitin (1 WM) in 50
mM Tris^HCl (pH 7.4), 2 mM ATP, 5 mM MgCl2, 2 mM DTT and
0.5 Wg/Wl lysate from BL21 E. coli transformed with pGEX-5X-1 in a
reaction volume of 15 Wl for 90 min at 30‡C. Reactions were termi-
nated by adding concentrated SDS^PAGE bu¡er, and analyzed by
15% SDS^PAGE and immunoblotting with anti-SNURF antibody.
Thiol ester assay reactions were performed according to Jensen et
al. [22]. After incubation at 30‡C for 2 h, reactions were terminated
by incubation in 25 mM Tris^HCl (pH 6.8), 5% (v/v) glycerol, 4%
lithium dodecyl sulfate, 4 M urea at 30‡C for 15 min. Samples were
subjected to non-reducing SDS^PAGE, and radioactively labeled pro-
teins were visualized by autoradiography.
3. Results
3.1. SNURF undergoes ubiquitination in an E2 conjugating
enzyme-selective fashion in vitro
To determine whether SNURF can mediate ubiquitination,
bacterially expressed, puri¢ed GST-SNURF was incubated
with recombinant E1 enzyme and di¡erent recombinant E2s
(HHR6B, UbcH3, UbcH5B, MmUbc6, MmUbc7, E2-20K,
UbcH13, UbcM4, and E2-25K produced in bacteria) in the
presence of 32P-labeled ubiquitin and bacterial lysate. In this
in vitro system, proteins present in the bacterial lysate and
SNURF served as potential substrates. Reactions were ana-
lyzed by SDS^PAGE and autoradiography. As shown in Fig.
1A, addition of GST-SNURF to the reactions containing
UbcH5B, MmUbc7, or E2-25K resulted in substantial mul-
ti-ubiquitination, while reactions with HHR6B and UbcH13
yielded predominately mono-ubiquitination. Also multi-ubiq-
uitination could be seen with HHR6B and UbcH13 upon
longer incubation times (data not shown). In contrast, no
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ubiquitination was evident with UbcH3, MmUbc6, UbcM4 or
E2-20K. The RING ¢nger E3 ligase AO7, however, was only
active with UbcH5B (Fig. 1B). The relative activity of the E2s
used is shown by thioester formation in Fig. 1C. Interestingly,
while AO7 binds tightly to UbcH5B [12], stable complexes
were not detected under in vitro conditions between GST-
SNURF and any of the E2s tested (data not shown).
To test the role of SNURF’s RING-HC motif for the ap-
parent ubiquitin ligase activity, GST-SNURF proteins con-
taining point mutations of the conserved cysteines in the
RING ¢nger motif (Fig. 2A) were studied in ubiquitination
using UbcH5B as the E2 enzyme (Fig. 2B). Replacement of
cysteines 136 and 139 by serines (C136/139S) in the putative
coordination structure of the ¢rst zinc ion or comparable
mutation in the second coordination structure (C177/180S)
abolished the ubiquitination activity of SNURF. Likewise,
deletion mutant 178^194 did not mediate ubiquitination. In-
terestingly, also deletion of the ¢rst 20 amino acids of
SNURF resulted in attenuation of the ubiquitination activity
(Fig. 2B). Comparable results were obtained when MmUbc7
was used as an E2 enzyme (data not shown). Taken together,
these results indicate that SNURF can mediate ubiquitination
in an E2 enzyme-selective fashion and that the intact RING
¢nger motif is mandatory for SNURF’s E3 activity.
Upon removal of GST-SNURF from the UbcH5B-contain-
ing reaction mixture with glutathione beads and washing of
the unbound proteins away, the large majority of the ubiqui-
tinated material remained bound to glutathione beads, indi-
cating that GST-SNURF represents the major ubiquitinated
species. To con¢rm that SNURF itself, and not the GST
moiety, was conjugated by ubiquitin, SNURF was cleaved
from the GST moiety and incubated with E1, UbcH5A and
ubiquitin and analyzed the reactions by immunoblotting with
anti-SNURF antibody. As shown in Fig. 2C, mainly mono-
and di-ubiquitinated SNURF species were detected when both
E1 and E2 were included in the reactions, con¢rming that
SNURF is self-ubiquitinated.
3.2. SNURF is ubiquitinated in intact cells
To study whether SNURF is ubiquitinated in intact cells,
we cotransfected COS-1 cells with expression plasmids encod-
ing HA-tagged ubiquitin and wild-type or RING ¢nger-mu-
tated (C136/139/177/180S) SNURF. Cell lysates were immu-
noprecipitated with anti-HA antibody resin, and bound
proteins were analyzed by immunoblotting with anti-SNURF
antibody. When HA-ubiquitin was co-expressed with
SNURF, higher molecular mass species indicative of ubiqui-
tinated SNURF forms were immunoprecipitated with the res-
Fig. 1. SNURF mediates E2-dependent ubiquitination in vitro. Glutathione bead-absorbed GST-SNURF (A) or GST-AO7 (B) was incubated
with 32P-labeled ubiquitin, recombinant E1 and various recombinant E2 enzymes (HHR6B, UbcH3, UbcM4, UbcH5B, UbcM6, UbcM7, Ubc8,
UbcH13, E2-20K, and E2-25K) for 2 h at 30‡C as described in Section 2. The ubiquitinating mixture was removed and the protein on beads
washed with 50 mM Tris^HCl, pH 7.4. Protein were separated by SDS^PAGE and ubiquitinated species were detected by autoradiography.
C: E2s used in A and B were incubated with recombinant E1 and 32P-labeled ubiquitin for 2 h at 30 ‡C and separated by SDS^PAGE under
non-reducing conditions to show relative activity of individual E2s. The arrowhead in A shows the smallest ubiquitinated SNURF form.
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in (Fig. 3). In accordance with the cell-free experiments, the
SNURF RING mutant showed no ubiquitination. Mainly
mono- and di-ubiquitinated SNURF species were detectable
in the absence of proteasomal inhibitor MG-132, and inclu-
sion of the inhibitor rendered tri- and tetra-ubiquitinated
SNURF species visible. While SNURF may target itself for
degradation, this is not the sole function of its E3 activity,
since the RING mutations did not stabilize the protein. Inter-
estingly however, treatment with MG-132 allowed detection
of higher levels of ubiquitinated SNURF (Fig. 3). Taken to-
gether, these results indicate that SNURF undergoes ubiqui-
tination also in intact cells.
3.3. Endogenous SNURF resides in large salt-resistant
complexes
Many RING ¢nger proteins are subunits in multiprotein
complexes [30]. To assess whether endogenous SNURF re-
sides in macromolecular complexes, we studied endogenous
SNURF protein in mouse embryonal carcinoma F9 cells in
which SNURF is abundantly expressed. We size-fractionated
F9 cell lysates by gel ¢ltration and analyzed the presence of
SNURF in the eluate fractions by immunoblotting with anti-
SNURF antibody. In contrast to puri¢ed recombinant
SNURF that eluted in low molecular mass fractions (Fig.
4A), the majority of endogenous SNURF in F9 cells resided
in v 500-kDa complexes that were stable at 0.45 M and 0.65
M NaCl (Fig. 4B and results not shown). The latter fractions
also contained the vast majority of RNA polymerase II large
subunit (Fig. 4C). A similar elution pattern for SNURF was
observed when protein lysates of mouse testis were fraction-
ated under identical chromatographic conditions (data not
shown). In addition to unmodi¢ed SNURF migrating at
V35 kDa, immunoblotting of the F9 cell-derived fractions
revealed the presence of higher molecular mass species of
SNURF in 9 200-kDa gel ¢ltration fractions (Fig. 4B), sug-
gesting that endogenous SNURF is ubiquitinated and that the
modi¢cation in£uences SNURF’s protein^protein interac-
tions.
Fig. 2. Intact RING ¢nger motif of SNURF is needed for ubiquitination. A: Schematic presentation of SNURF, SNURF RING ¢nger, and
SNURF mutants used in in vitro ubiquitination studies. Conserved cysteines and histidine of RING ¢nger motif are underlined. The proposed
‘cross-brace’ RING C3HC4-type structure, where the zinc coordinating residues are pointed. Arrowheads indicate location of cysteine to serine
mutations in the RING ¢nger. B: GST, GST-SNURF and GST fusion of SNURF mutants C136S/C139S, C177/180S, C136/C139/C177/180S,
v1^20, v66^98, v178^194, R8-11A/K9A were incubated with UbcH5B and analyzed as described in Fig. 1. C: Ubiquitination of GST-cleaved
SNURF incubated with ubiquitin (Ub) in the presence (+) and absence (3) of recombinant E1 and GST-UbcH5A at 30‡C for 90 min. The re-
actions were analyzed by immunoblotting with anti-SNURF antibody. Positions of GST-SNURF (B) and of SNURF (C) are depicted by ar-
rows and free ubiquitin (32P-Ub) by the arrowhead.
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4. Discussion
Here, we show that the transcriptional coregulator
SNURF/RNF4 possesses ubiquitin E3 ligase activity. As in
the case of AO7, Mdm2, c-Cbl and ROC1 [12,21,31,32], an
intact RING ¢nger motif of SNURF was mandatory for the
E3 ligase function; disruption by point mutations or deletion
of the RING ¢nger motif abolished the catalytic activity.
RING ¢nger ubiquitin ligases can be divided into single-
and multi-subunit E3s. Single-subunit RING E3s, such as
proto-oncoproteins Mdm2 (murine double minute 2) and c-
Cbl [21,31], harbor the substrate recognition element and the
RING ¢nger in the same polypeptide. Multi-subunit RING
E3s come in at least in three types: SCF (Skp-1^Cullin^F-box
protein), APC (anaphase-promoting complex), and the VCB
(von Hippel^Lindau^elongin C/elongin B) complexes, which
all have a small RING ¢nger protein, such as ROC1, and a
member of the Cullin family of proteins as well as other sub-
units some of which recognize substrates [19,30]. The majority
of endogenous SNURF was found in salt-resistant high mo-
lecular mass complexes in murine F9 cells, implying that this
small nuclear RING ¢nger protein may act as a RING com-
ponent in a multi-subunit protein complex.
The E3 activity of SNURF was E2 enzyme-selective;
SNURF was clearly active with HHR6B (RAD6B), UbcH5A,
UbcH5B, MmUbc7, UbcH13 and E2-25K, whereas it showed
no activity with UbcH3 (cdc34), MmUbc6, UbcM4 or E2-
20K. While this multiple use of E2s is not unique to SNURF,
it is clearly not a general feature of RING proteins, as other
RING E3s mediate ubiquitination by a much more limited set
of E2s; for example, AO7 (Fig. 1B), and BRCA1 [33] use only
members of the UbcH5 family.
UbcH5 family E2s have recently been shown to function
with several RING ¢nger E3s, including RLIM (RING ¢nger
Fig. 3. SNURF is ubiquitinated in intact cells. COS-1 cells were co-
transfected with wild-type or RING ¢nger mutant (C136/139/177/
180S) of FLAG-SNURF alone or with HA-ubiquitin expression
plasmids as indicated by + and 3 signs. After 36 h transfection,
cells were treated with (+) or without (3) MG-132 (1.5 WM) and
harvested 12 h after that. Upper panel: Ubiquitinated proteins were
immunoprecipitated with anti-HA antibody resin, eluted and ana-
lyzed by SDS^PAGE and immunoblotting with anti-SNURF anti-
body. Lower panel: Immunoblot analysis of the corresponding
whole cell lysates using anti-SNURF antibody. Migrations of
SNURF species modi¢ed by one or two ubiquitin moieties are indi-
cated by arrowheads and an arrow shows the position of unmodi-
¢ed SNURF. The asterisk indicates the position of IgG heavy
chain.
Fig. 4. Analysis of endogenous SNURF complexes of F9 cells by gel ¢ltration chromatography. Puri¢ed recombinant SNURF (A) and whole
cell extracts from F9 cells (B,C) were chromatographed on a Superose 6 HR10/30 column in a bu¡er containing 450 mM NaCl. The resulting
0.3-ml fractions (every other fraction as indicated) were subjected to immunoblot analysis with anti-SNURF antibody (A,B) or anti-RNA poly-
merase II (large subunit) antibody (C). Elution positions of size marker proteins (in kDa) analyzed under identical running conditions are de-
picted by arrowheads. (i, input sample.)
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LIM domain-binding protein) and Mdm2 as well as multi-
subunit RING E3s SCF and APC, and to ubiquitinate tumor
suppressor p53, CLIM (a cofactor of LIM homeodomain
transcription factors) [34^36]. HHR6 is a human counterpart
of yeast DNA repair protein RAD6 which can ubiquitinate
histones H2A, H2B and H3 and thereby regulate chromatin
structure [37^39]. UbcH13, the human homologue of Droso-
phila bendless, has recently been shown to form lysine 63-
linked ubiquitin chains that activate IUB kinase [28]. E2-25K
is the huntingtin-interacting protein-2 (HIP-2) [25], whose
physiological signi¢cance is not well de¢ned. It can act as
an E2 with RING2, an integrin-binding protein, but the latter
E3 activity and integrin signaling have not been linked [40].
Furthermore, the p105 subunit of NF-UB is degraded in an
E2-25K-dependent manner, but the E3 of the reaction is un-
known [41]. Our results show that SNURF is an E3 with
UbcH5 and E2-25K for which there are several possible sub-
strates.
We have attempted to ¢nd a role for SNURF as an E3
ligase with its interaction partners Sp1 and AR, but have
not found SNURF-dependent alteration in ubiquitination of
these two proteins. However, our studies do not preclude a
role for SNURF in the ubiquitination of other transcription
factors. The mechanism by which RING ¢nger proteins pro-
mote ubiquitination is not fully understood, but it is likely
that the RING E3s serve as adapters between the E2 enzyme
and the target protein [19]. Nevertheless, most of the RING
¢nger proteins that have thus far been shown to mediate
ubiquitination in cell-free systems lack de¢ned substrates oth-
er than themselves. Also the signi¢cance of auto-ubiquitina-
tion of E3 ligases has remained elusive. Auto-ubiquitination
may regulate the turn-over of E3s (MDM2, DIAP1) [21], or
serve as a means to regulate their E3 activity or tumor sup-
pressor function (BRCA1) [42].
SNURF showed mainly mono- and di-ubiquitination in
intact cells. In contrast to poly-ubiquitination, mono- and
di-ubiquitination do not serve as proteasome targeting signals
[16]. This result, along with the ¢nding that RING mutants of
SNURF were not more stable than wild type protein, indi-
cates that the E3 activity does not simply target SNURF to
degradation. Instead, it is clearly connected to SNURF’s
function as a transcriptional and cell growth regulator, since
mutations that inactivate the E3 function abolish both
SNURF’s coregulatory activity with many transcription fac-
tors and its ability to inhibit cell proliferation in germ cell
tumor-derived cells [5,8,9,43]. Collectively, our results that
SNURF possesses ubiquitin-conjugating enzyme-selective E3
ligase activity provide an important new insight into the func-
tion of this interesting transcriptional coregulator.
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